EPISODE · Sep 5, 2024 · 30 MIN
Emerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MD
from Rx for Biotech · host Podcast Host Chris Leidli
In this podcast episode, we sit down with Christopher Heery, the Chief Medical Officer at Arcellx to learn about the company's pipeline and lead cell therapy, anitocabtagene autoleucel, or anito-cel, that is in development for multiple myeloma. Multiple myeloma, like lymphoma and leukemia are types of cancer that start in your blood cells.
What this episode covers
In this podcast episode, we sit down with Christopher Heery, the Chief Medical Officer at Arcellx to learn about the company's pipeline and lead cell therapy, anitocabtagene autoleucel, or anito-cel, that is in development for multiple myeloma. Multiple myeloma, like lymphoma and leukemia are types of cancer that start in your blood cells.
NOW PLAYING
Emerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MD
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m